Regulatory Resources

Updated September 21, 2021

AGD continues to monitor COVID-19-related dental practice and regulatory activities and advocate for programs that support general dentists. The following resources have been updated to assist AGD members during this time. 


New ADA Codes for COVID-19 Vaccination Procedures and Molecular Testing Added to CDT 2021

AGD sends letter to CDC, NIAID, and White House on inhalation exposure. 3.12.21 

A Report Prepared for the Chief Dental Officer of Canada on the Safe Return to Clinical Practice 

HHS Assistant Secretary for Preparedness and Response Guidance Updates 11.20.20 

COVID-19 Vaccination Training Programs and Reference Materials for Healthcare Professionals 11.17.20 

FDA Issues Recommendations for Certain High-Risk Groups Regarding Mercury-Containing Dental Amalgam 

Final National Academies of Sciences, Engineering, and Medicine on the Framework for the Equitable Allocation of COVID-19 Vaccine 

CDC Scientific Brief: SARS-CoV-2 and Potential Airborne Transmission 

Cochrane Oral Health: Aerosol generating procedures and their mitigation in international guidance documents 

Frequently Asked Questions on PPE

The Dental Practice Council drafted a response to a frequently asked PPE question about the differences in guidance between the Occupational Safety and Health Administration (OSHA) and the Centers for Disease Control and Prevention (CDC) documents. The AGD outlines steps if you experience a shortage of N95 masks in your area. Learn more. 

Center for Disease Control Guidance Updates:

The CDC has released updated guidance for dental settings during COVID-19. Check out the update

The CDC has released Interim Infection Prevention and Control Guidance for Dental Settings during COVID-19 Response on July 15, 2020. Check out the update.  

Implementing Filtering Facepiece Respirator (FFR) Reuse, Including Reuse after Decontamination, When There Are Known Shortages of N95 Respirators 8.3.2020
Learn how to decontaminate and reuse filtering facepiece respirators.

Interim Guidelines for COVID-19 Antibody Testing
CDC has developed interim guidance for how healthcare providers, laboratories, and public health staff should use antibody tests for COVID-19. These tests look for the presence of antibodies, which are specific proteins made in response to infections. 7.31.2020

Guidance for Healthcare Workers about COVID-19 (SARS-CoV-2) Testing
See considerations and recommendations for health departments supporting COVID-19 (SARS-CoV-2) testing in communities, schools, workplaces, and healthcare settings. 7.30.2020

Managing Investigations During an Outbreak
Learn about managing investigations during a COVID-19 outbreak in congregate settings, correctional facilities, workplaces, healthcare settings, schools, and homeless shelters. 7.30.2020

Overview of Testing for SARS-CoV-2
Summary of considerations and current CDC recommendations regarding SARS-CoV-2 testing. 7.27.2020

Considerations for Release of Stockpiled N95s Beyond the Manufacturer-Designated Shelf Life
Find CDC's considerations for using expired N95 respirators during COVID-19. 7.19.2020

Interim Guidance on Testing Healthcare Personnel for SARS-CoV-2 7.16.2020


U.S. Centers for Disease Control and Prevention

U.S. Center for Medicare & Medicaid Services

U.S. Department of Labor

U.S. Environmental Protection Agency (EPA)

U.S. Internal Revenue Service

U.S. Food and Drug Administration

U.S. Office, Occupational Safety and Health Administration

U.S. Office, Assistant Secretary for Preparedness and Response

U.S. Military

Organization for Safety, Asepsis and Prevention (OSAP)

Department of Homeland Security Science and Technology

State Information

Government of Canada